Maggie Stanislawski
Concepts (490)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Gastrointestinal Microbiome | 8 | 2023 | 641 | 2.120 |
Why?
| Microbiota | 8 | 2023 | 734 | 1.710 |
Why?
| Obesity | 8 | 2024 | 2885 | 1.020 |
Why?
| Body Mass Index | 7 | 2024 | 2274 | 0.790 |
Why?
| Percutaneous Coronary Intervention | 11 | 2020 | 467 | 0.780 |
Why?
| United States Department of Veterans Affairs | 14 | 2020 | 628 | 0.770 |
Why?
| Behavior Therapy | 2 | 2021 | 241 | 0.770 |
Why?
| Fatty Liver | 2 | 2021 | 230 | 0.710 |
Why?
| Lipopolysaccharide Receptors | 1 | 2021 | 86 | 0.690 |
Why?
| Weight Loss | 2 | 2021 | 740 | 0.630 |
Why?
| Inflammatory Bowel Diseases | 1 | 2023 | 326 | 0.630 |
Why?
| Biostatistics | 1 | 2018 | 16 | 0.590 |
Why?
| Pacemaker, Artificial | 4 | 2020 | 111 | 0.550 |
Why?
| Coronary Artery Disease | 6 | 2023 | 680 | 0.550 |
Why?
| Weight Gain | 2 | 2018 | 510 | 0.550 |
Why?
| Gastrointestinal Tract | 1 | 2019 | 187 | 0.520 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2021 | 2062 | 0.520 |
Why?
| Insulin Resistance | 3 | 2024 | 1168 | 0.520 |
Why?
| Bacteria | 3 | 2020 | 814 | 0.500 |
Why?
| Phylogeny | 2 | 2018 | 845 | 0.490 |
Why?
| Glucose Oxidase | 7 | 1994 | 26 | 0.470 |
Why?
| Prosthesis-Related Infections | 4 | 2020 | 75 | 0.460 |
Why?
| Non-alcoholic Fatty Liver Disease | 1 | 2018 | 260 | 0.460 |
Why?
| Pediatric Obesity | 2 | 2019 | 573 | 0.460 |
Why?
| Antibiotic Prophylaxis | 3 | 2020 | 102 | 0.440 |
Why?
| Liver | 9 | 2020 | 1839 | 0.440 |
Why?
| RNA, Ribosomal, 16S | 5 | 2018 | 524 | 0.430 |
Why?
| Feces | 4 | 2021 | 442 | 0.410 |
Why?
| Veterans Health | 4 | 2018 | 179 | 0.410 |
Why?
| Phenotype | 6 | 2023 | 3062 | 0.410 |
Why?
| Lactoperoxidase | 7 | 1994 | 7 | 0.390 |
Why?
| Risk Factors | 15 | 2023 | 9801 | 0.370 |
Why?
| Coronary Artery Bypass | 4 | 2017 | 224 | 0.350 |
Why?
| Peroxidases | 5 | 1993 | 34 | 0.350 |
Why?
| Pregnancy | 7 | 2021 | 6423 | 0.340 |
Why?
| Humans | 56 | 2024 | 129847 | 0.340 |
Why?
| Female | 44 | 2024 | 68829 | 0.340 |
Why?
| Immunotoxins | 4 | 1990 | 54 | 0.320 |
Why?
| Male | 37 | 2024 | 63759 | 0.310 |
Why?
| Veterans | 7 | 2018 | 1383 | 0.310 |
Why?
| Cardiovascular Diseases | 1 | 2021 | 2008 | 0.310 |
Why?
| Dextrans | 5 | 1988 | 84 | 0.300 |
Why?
| Immunoglobulin Idiotypes | 7 | 1988 | 27 | 0.290 |
Why?
| Middle Aged | 27 | 2024 | 31177 | 0.290 |
Why?
| Bifidobacterium | 2 | 2017 | 21 | 0.280 |
Why?
| Myocardial Infarction | 6 | 2018 | 1021 | 0.280 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2021 | 2444 | 0.270 |
Why?
| Coronary Angiography | 7 | 2020 | 306 | 0.270 |
Why?
| Anti-Infective Agents | 2 | 2020 | 249 | 0.240 |
Why?
| Aged | 22 | 2024 | 22107 | 0.240 |
Why?
| Defibrillators, Implantable | 2 | 2020 | 300 | 0.230 |
Why?
| Radial Artery | 2 | 2017 | 69 | 0.230 |
Why?
| Time Factors | 11 | 2021 | 6550 | 0.230 |
Why?
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 486 | 0.230 |
Why?
| Diet | 3 | 2023 | 1212 | 0.220 |
Why?
| T-Lymphocytes | 8 | 1995 | 1937 | 0.220 |
Why?
| HIV-1 | 3 | 1995 | 839 | 0.220 |
Why?
| Registries | 3 | 2019 | 1903 | 0.210 |
Why?
| Risk Assessment | 4 | 2021 | 3269 | 0.210 |
Why?
| Child | 6 | 2021 | 20962 | 0.210 |
Why?
| United States | 20 | 2020 | 13913 | 0.210 |
Why?
| Plasmacytoma | 8 | 1989 | 16 | 0.200 |
Why?
| Renal Insufficiency, Chronic | 2 | 2020 | 567 | 0.200 |
Why?
| Age Factors | 2 | 2021 | 3161 | 0.200 |
Why?
| Electronic Health Records | 2 | 2020 | 979 | 0.200 |
Why?
| Metagenomics | 1 | 2023 | 156 | 0.190 |
Why?
| Norway | 2 | 2018 | 42 | 0.190 |
Why?
| Patient Identification Systems | 2 | 2019 | 16 | 0.190 |
Why?
| Mothers | 2 | 2018 | 731 | 0.190 |
Why?
| Acute Kidney Injury | 2 | 2020 | 791 | 0.180 |
Why?
| Mississippi | 1 | 2021 | 21 | 0.180 |
Why?
| Proton Therapy | 1 | 2021 | 12 | 0.180 |
Why?
| Incidence | 4 | 2021 | 2646 | 0.180 |
Why?
| Diet, Reducing | 1 | 2021 | 87 | 0.180 |
Why?
| Waist Circumference | 1 | 2021 | 138 | 0.180 |
Why?
| Gardening | 1 | 2020 | 10 | 0.170 |
Why?
| Caloric Restriction | 1 | 2021 | 111 | 0.170 |
Why?
| DNA, Bacterial | 2 | 2018 | 323 | 0.170 |
Why?
| Cohort Studies | 6 | 2020 | 5444 | 0.160 |
Why?
| Fasting | 1 | 2021 | 268 | 0.160 |
Why?
| Weight Reduction Programs | 1 | 2021 | 110 | 0.160 |
Why?
| Precision Medicine | 1 | 2023 | 385 | 0.160 |
Why?
| Mice, Inbred BALB C | 14 | 1989 | 1248 | 0.160 |
Why?
| Western World | 1 | 2019 | 7 | 0.160 |
Why?
| Machine Learning | 1 | 2024 | 441 | 0.160 |
Why?
| Cardiac Catheterization | 3 | 2018 | 520 | 0.160 |
Why?
| Atherosclerosis | 1 | 2023 | 402 | 0.160 |
Why?
| Adult | 9 | 2023 | 35634 | 0.160 |
Why?
| Fluid Therapy | 1 | 2020 | 133 | 0.160 |
Why?
| Proportional Hazards Models | 6 | 2018 | 1199 | 0.150 |
Why?
| Intra-Aortic Balloon Pumping | 1 | 2019 | 17 | 0.150 |
Why?
| Adolescent | 5 | 2021 | 20451 | 0.150 |
Why?
| Epidemiology | 1 | 2018 | 15 | 0.150 |
Why?
| Perioperative Care | 1 | 2020 | 166 | 0.150 |
Why?
| Prospective Studies | 3 | 2021 | 7158 | 0.150 |
Why?
| Genome-Wide Association Study | 2 | 2023 | 1326 | 0.150 |
Why?
| Practice Patterns, Physicians' | 2 | 2017 | 1274 | 0.140 |
Why?
| Documentation | 1 | 2020 | 185 | 0.140 |
Why?
| Stress Disorders, Post-Traumatic | 2 | 2017 | 813 | 0.140 |
Why?
| Drug Users | 1 | 2018 | 41 | 0.140 |
Why?
| Antibodies, Monoclonal | 10 | 2016 | 1368 | 0.140 |
Why?
| Clostridium Infections | 1 | 2018 | 64 | 0.140 |
Why?
| Vancomycin | 1 | 2018 | 78 | 0.140 |
Why?
| Streptococcus | 1 | 2017 | 26 | 0.140 |
Why?
| Genes, rRNA | 1 | 2017 | 41 | 0.140 |
Why?
| Antiviral Agents | 2 | 1994 | 719 | 0.140 |
Why?
| Homeostasis | 1 | 2021 | 605 | 0.140 |
Why?
| Atherectomy, Coronary | 1 | 2017 | 10 | 0.140 |
Why?
| Young Adult | 5 | 2021 | 12467 | 0.140 |
Why?
| Behavior, Addictive | 1 | 2018 | 81 | 0.140 |
Why?
| History, 21st Century | 1 | 2018 | 186 | 0.140 |
Why?
| Coronary Stenosis | 1 | 2017 | 39 | 0.140 |
Why?
| Antibodies | 8 | 1983 | 399 | 0.140 |
Why?
| Contrast Media | 1 | 2020 | 394 | 0.140 |
Why?
| Coronary Occlusion | 1 | 2017 | 18 | 0.140 |
Why?
| Blood Transfusion | 2 | 2017 | 298 | 0.140 |
Why?
| Dysbiosis | 1 | 2018 | 170 | 0.130 |
Why?
| Cocaine-Related Disorders | 1 | 2018 | 108 | 0.130 |
Why?
| Data Collection | 1 | 2020 | 653 | 0.130 |
Why?
| Population Surveillance | 1 | 2020 | 439 | 0.130 |
Why?
| Psychological Trauma | 1 | 2017 | 54 | 0.130 |
Why?
| Myeloma Proteins | 8 | 1984 | 14 | 0.130 |
Why?
| Infant, Newborn | 2 | 2018 | 5772 | 0.130 |
Why?
| Peroxidase | 2 | 1994 | 175 | 0.130 |
Why?
| Binding Sites, Antibody | 6 | 1988 | 42 | 0.130 |
Why?
| Program Evaluation | 3 | 2017 | 878 | 0.130 |
Why?
| Immunoglobulin G | 11 | 1988 | 851 | 0.130 |
Why?
| Antigens | 11 | 1979 | 356 | 0.130 |
Why?
| Comorbidity | 2 | 2018 | 1551 | 0.130 |
Why?
| Mice, Inbred Strains | 5 | 1987 | 408 | 0.130 |
Why?
| Career Choice | 1 | 2018 | 206 | 0.130 |
Why?
| Glucose | 1 | 2021 | 1003 | 0.130 |
Why?
| Adipose Tissue | 1 | 2020 | 594 | 0.120 |
Why?
| Mycoplasma | 1 | 1995 | 5 | 0.120 |
Why?
| Femoral Artery | 1 | 2017 | 174 | 0.120 |
Why?
| Genetic Predisposition to Disease | 2 | 2021 | 2271 | 0.120 |
Why?
| Vascular Calcification | 1 | 2017 | 107 | 0.120 |
Why?
| Mycoplasma Infections | 1 | 1995 | 15 | 0.120 |
Why?
| Treatment Outcome | 10 | 2019 | 10241 | 0.120 |
Why?
| Algorithms | 2 | 2020 | 1617 | 0.120 |
Why?
| Hemorrhage | 2 | 2017 | 680 | 0.120 |
Why?
| Cross Reactions | 5 | 1988 | 133 | 0.120 |
Why?
| Antibody Specificity | 10 | 1989 | 185 | 0.120 |
Why?
| Medication Errors | 1 | 2016 | 96 | 0.120 |
Why?
| Research Report | 1 | 2016 | 79 | 0.120 |
Why?
| Blood Glucose | 2 | 2024 | 2103 | 0.120 |
Why?
| Social Determinants of Health | 1 | 2018 | 226 | 0.120 |
Why?
| Diabetes Mellitus | 1 | 2023 | 1003 | 0.120 |
Why?
| Prognosis | 2 | 2021 | 3773 | 0.120 |
Why?
| Myocardial Ischemia | 1 | 2016 | 259 | 0.110 |
Why?
| Delivery of Health Care, Integrated | 1 | 2017 | 250 | 0.110 |
Why?
| Saphenous Vein | 1 | 2014 | 32 | 0.110 |
Why?
| Infant | 2 | 2018 | 9018 | 0.110 |
Why?
| Arterial Occlusive Diseases | 1 | 2014 | 80 | 0.110 |
Why?
| Drug-Eluting Stents | 1 | 2014 | 74 | 0.110 |
Why?
| Antimicrobial Stewardship | 1 | 2016 | 107 | 0.110 |
Why?
| Premature Birth | 1 | 2017 | 317 | 0.110 |
Why?
| Hydrogen Peroxide | 1 | 1995 | 317 | 0.110 |
Why?
| Patient Selection | 2 | 2016 | 660 | 0.110 |
Why?
| Stents | 2 | 2014 | 504 | 0.110 |
Why?
| Aged, 80 and over | 6 | 2024 | 7066 | 0.110 |
Why?
| Child, Preschool | 2 | 2018 | 10522 | 0.100 |
Why?
| Methionine Sulfoximine | 2 | 1990 | 2 | 0.100 |
Why?
| Lymphocyte Depletion | 2 | 1990 | 134 | 0.100 |
Why?
| Carmustine | 2 | 1990 | 50 | 0.100 |
Why?
| Renal Dialysis | 1 | 2017 | 423 | 0.100 |
Why?
| Overweight | 1 | 2017 | 531 | 0.100 |
Why?
| Retrospective Studies | 10 | 2020 | 14553 | 0.100 |
Why?
| Bone Marrow Transplantation | 2 | 1990 | 277 | 0.100 |
Why?
| Platelet Aggregation Inhibitors | 1 | 2016 | 443 | 0.100 |
Why?
| Databases, Factual | 4 | 2019 | 1269 | 0.100 |
Why?
| Military Personnel | 1 | 2018 | 521 | 0.100 |
Why?
| Chi-Square Distribution | 3 | 2018 | 515 | 0.090 |
Why?
| Anti-Bacterial Agents | 2 | 2020 | 1708 | 0.090 |
Why?
| Immunoglobulin Allotypes | 3 | 1986 | 9 | 0.090 |
Why?
| Kidney Failure, Chronic | 1 | 2017 | 546 | 0.090 |
Why?
| Nitrohydroxyiodophenylacetate | 2 | 1988 | 3 | 0.090 |
Why?
| Healthcare Disparities | 1 | 2017 | 580 | 0.090 |
Why?
| Bone Marrow | 2 | 1989 | 272 | 0.090 |
Why?
| Sex Factors | 1 | 2017 | 1973 | 0.090 |
Why?
| Tomography, X-Ray Computed | 1 | 2021 | 2511 | 0.090 |
Why?
| Coronary Disease | 1 | 2013 | 385 | 0.090 |
Why?
| Rabbits | 15 | 1983 | 778 | 0.090 |
Why?
| Hospitals, Veterans | 3 | 2018 | 242 | 0.090 |
Why?
| Insulin | 1 | 2021 | 2330 | 0.090 |
Why?
| Plasma Cells | 3 | 1976 | 66 | 0.090 |
Why?
| Antigens, Neoplasm | 4 | 1990 | 308 | 0.090 |
Why?
| Magnetic Resonance Imaging | 2 | 2021 | 3397 | 0.080 |
Why?
| Pediatrics | 1 | 2018 | 1074 | 0.080 |
Why?
| Prevalence | 4 | 2018 | 2564 | 0.080 |
Why?
| Cross-Sectional Studies | 1 | 2021 | 5085 | 0.080 |
Why?
| Stroke | 1 | 2018 | 1072 | 0.080 |
Why?
| Biomarkers | 1 | 2021 | 3971 | 0.080 |
Why?
| Antibodies, Anti-Idiotypic | 3 | 1985 | 58 | 0.080 |
Why?
| Hospitalization | 2 | 2016 | 2079 | 0.080 |
Why?
| Antibody-Dependent Cell Cytotoxicity | 1 | 1988 | 20 | 0.080 |
Why?
| Immunoglobulin Isotypes | 1 | 1988 | 34 | 0.080 |
Why?
| Mice | 30 | 1989 | 16983 | 0.080 |
Why?
| Animals | 42 | 2021 | 35409 | 0.080 |
Why?
| Immune Sera | 11 | 1985 | 87 | 0.080 |
Why?
| Glycoproteins | 1 | 1990 | 338 | 0.080 |
Why?
| Immunoglobulin Heavy Chains | 4 | 1986 | 79 | 0.070 |
Why?
| Immunoglobulin M | 6 | 1983 | 276 | 0.070 |
Why?
| Species Specificity | 2 | 1988 | 568 | 0.070 |
Why?
| Colorado | 1 | 2018 | 4410 | 0.070 |
Why?
| Adjuvants, Immunologic | 2 | 1988 | 222 | 0.070 |
Why?
| Antibodies, Neoplasm | 2 | 1979 | 34 | 0.070 |
Why?
| Nitrophenols | 1 | 1987 | 33 | 0.070 |
Why?
| Cell Line | 6 | 1995 | 2780 | 0.070 |
Why?
| Immunoglobulins | 7 | 1984 | 162 | 0.070 |
Why?
| Health Services Accessibility | 1 | 2014 | 903 | 0.070 |
Why?
| Receptors, Antigen, B-Cell | 5 | 1979 | 126 | 0.060 |
Why?
| Antigen-Antibody Complex | 1 | 1986 | 86 | 0.060 |
Why?
| Killer Cells, Natural | 2 | 1988 | 426 | 0.060 |
Why?
| Immunoglobulin Variable Region | 3 | 1983 | 79 | 0.060 |
Why?
| Immunoelectrophoresis | 11 | 1976 | 16 | 0.060 |
Why?
| Surveys and Questionnaires | 1 | 2018 | 5437 | 0.060 |
Why?
| Genes, MHC Class II | 2 | 1983 | 73 | 0.060 |
Why?
| Kaplan-Meier Estimate | 2 | 2018 | 851 | 0.060 |
Why?
| Hypertension, Pulmonary | 1 | 2016 | 1897 | 0.060 |
Why?
| B-Lymphocytes | 3 | 1979 | 816 | 0.050 |
Why?
| p-Azobenzenearsonate | 1 | 1983 | 4 | 0.050 |
Why?
| Longitudinal Studies | 2 | 2021 | 2724 | 0.050 |
Why?
| Azo Compounds | 1 | 1983 | 27 | 0.050 |
Why?
| Cluster Analysis | 1 | 2024 | 483 | 0.050 |
Why?
| Mice, Inbred A | 3 | 1988 | 48 | 0.050 |
Why?
| Lymphocytes | 3 | 1979 | 377 | 0.050 |
Why?
| Immunoglobulin kappa-Chains | 2 | 1979 | 20 | 0.050 |
Why?
| Receptors, Immunologic | 1 | 1983 | 216 | 0.050 |
Why?
| Logistic Models | 2 | 2017 | 1989 | 0.050 |
Why?
| Multiple Myeloma | 3 | 1984 | 125 | 0.050 |
Why?
| Adsorption | 4 | 1975 | 139 | 0.050 |
Why?
| Kinetics | 6 | 1989 | 1645 | 0.040 |
Why?
| Binding, Competitive | 4 | 1983 | 206 | 0.040 |
Why?
| Diet Surveys | 1 | 2021 | 92 | 0.040 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 1 | 1990 | 1560 | 0.040 |
Why?
| Lymph Nodes | 5 | 1985 | 471 | 0.040 |
Why?
| Radiometry | 1 | 2021 | 48 | 0.040 |
Why?
| Microsomes | 4 | 1975 | 35 | 0.040 |
Why?
| Antibody Formation | 5 | 1987 | 291 | 0.040 |
Why?
| Lipase | 1 | 2021 | 66 | 0.040 |
Why?
| Neoplasms, Experimental | 4 | 1979 | 171 | 0.040 |
Why?
| Immunoglobulin Fab Fragments | 3 | 2016 | 59 | 0.040 |
Why?
| HIV Infections | 1 | 1995 | 2730 | 0.040 |
Why?
| Protons | 1 | 2021 | 82 | 0.040 |
Why?
| Forehead | 1 | 2020 | 6 | 0.040 |
Why?
| Consensus | 1 | 2023 | 622 | 0.040 |
Why?
| Patient Readmission | 2 | 2017 | 668 | 0.040 |
Why?
| Genetic Markers | 1 | 2021 | 334 | 0.040 |
Why?
| Phantoms, Imaging | 1 | 2021 | 137 | 0.040 |
Why?
| Buthionine Sulfoximine | 2 | 1990 | 8 | 0.040 |
Why?
| Sodium Bicarbonate | 1 | 2020 | 37 | 0.040 |
Why?
| Free Radical Scavengers | 1 | 2020 | 83 | 0.040 |
Why?
| Mouth | 1 | 2020 | 84 | 0.040 |
Why?
| Gene-Environment Interaction | 1 | 2021 | 185 | 0.040 |
Why?
| Datasets as Topic | 1 | 2020 | 109 | 0.040 |
Why?
| Immunoglobulin mu-Chains | 1 | 1979 | 9 | 0.040 |
Why?
| Evidence-Based Medicine | 1 | 2023 | 716 | 0.040 |
Why?
| Acetylcysteine | 1 | 2020 | 146 | 0.040 |
Why?
| Clinical Laboratory Techniques | 1 | 2020 | 94 | 0.040 |
Why?
| Metabolomics | 1 | 2024 | 652 | 0.040 |
Why?
| Antigens, CD | 2 | 1993 | 487 | 0.040 |
Why?
| Immunoglobulin Light Chains | 1 | 1979 | 40 | 0.040 |
Why?
| Quality Improvement | 2 | 2018 | 1112 | 0.040 |
Why?
| Oceania | 1 | 2018 | 4 | 0.040 |
Why?
| Carrier Proteins | 1 | 1983 | 741 | 0.040 |
Why?
| Critical Pathways | 1 | 2020 | 86 | 0.040 |
Why?
| Child Behavior | 1 | 2021 | 236 | 0.040 |
Why?
| Intraoperative Period | 1 | 2019 | 55 | 0.040 |
Why?
| Drug Synergism | 2 | 1990 | 370 | 0.040 |
Why?
| Linear Models | 1 | 2021 | 822 | 0.040 |
Why?
| Antigens, Surface | 1 | 1979 | 152 | 0.040 |
Why?
| Teratoma | 1 | 1979 | 103 | 0.040 |
Why?
| Peptides | 4 | 2016 | 926 | 0.040 |
Why?
| Mice, Inbred C57BL | 9 | 1988 | 5468 | 0.040 |
Why?
| Erythrocytes | 3 | 1989 | 673 | 0.040 |
Why?
| Cattle | 1 | 2021 | 978 | 0.040 |
Why?
| Genes, Regulator | 1 | 1978 | 35 | 0.040 |
Why?
| Skin | 1 | 2023 | 725 | 0.040 |
Why?
| Proteomics | 1 | 2024 | 1058 | 0.040 |
Why?
| Glutathione | 2 | 1990 | 349 | 0.040 |
Why?
| Drug Prescriptions | 1 | 2020 | 249 | 0.040 |
Why?
| Mice, Inbred C3H | 4 | 1988 | 271 | 0.040 |
Why?
| Europe | 1 | 2018 | 363 | 0.040 |
Why?
| Echocardiography, Stress | 1 | 2017 | 20 | 0.040 |
Why?
| North America | 1 | 2018 | 294 | 0.040 |
Why?
| Punctures | 1 | 2017 | 40 | 0.030 |
Why?
| Residence Characteristics | 1 | 2020 | 332 | 0.030 |
Why?
| Dose-Response Relationship, Immunologic | 2 | 1989 | 82 | 0.030 |
Why?
| Transfusion Reaction | 1 | 2017 | 43 | 0.030 |
Why?
| Surgical Wound Infection | 1 | 2020 | 283 | 0.030 |
Why?
| Hematopoietic Stem Cells | 2 | 1990 | 382 | 0.030 |
Why?
| Self Report | 1 | 2021 | 800 | 0.030 |
Why?
| Fibrosarcoma | 1 | 1976 | 21 | 0.030 |
Why?
| RNA, Bacterial | 1 | 2017 | 182 | 0.030 |
Why?
| Feasibility Studies | 1 | 2020 | 870 | 0.030 |
Why?
| Contraindications | 1 | 2016 | 90 | 0.030 |
Why?
| Glomerular Filtration Rate | 1 | 2020 | 711 | 0.030 |
Why?
| Adolescent Behavior | 1 | 2021 | 507 | 0.030 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 221 | 0.030 |
Why?
| Drug Labeling | 1 | 2016 | 41 | 0.030 |
Why?
| Drug Utilization Review | 1 | 2016 | 57 | 0.030 |
Why?
| Pregnancy Outcome | 1 | 2018 | 392 | 0.030 |
Why?
| Health Behavior | 1 | 2021 | 743 | 0.030 |
Why?
| Vasodilator Agents | 1 | 2017 | 326 | 0.030 |
Why?
| Risk-Taking | 1 | 2018 | 348 | 0.030 |
Why?
| Electrophoresis, Polyacrylamide Gel | 6 | 1993 | 338 | 0.030 |
Why?
| Device Removal | 1 | 2016 | 136 | 0.030 |
Why?
| Fluorescence | 1 | 1995 | 156 | 0.030 |
Why?
| Membrane Proteins | 1 | 2021 | 1119 | 0.030 |
Why?
| Cell Survival | 2 | 1990 | 1086 | 0.030 |
Why?
| Immunodiffusion | 7 | 1974 | 15 | 0.030 |
Why?
| Bioprosthesis | 1 | 2014 | 40 | 0.030 |
Why?
| Phytohemagglutinins | 1 | 1994 | 29 | 0.030 |
Why?
| HIV Core Protein p24 | 1 | 1994 | 31 | 0.030 |
Why?
| Odds Ratio | 1 | 2017 | 1022 | 0.030 |
Why?
| Immune Tolerance | 3 | 1993 | 356 | 0.030 |
Why?
| Angina, Unstable | 1 | 2014 | 76 | 0.030 |
Why?
| Survival Rate | 1 | 2019 | 1872 | 0.030 |
Why?
| Radioimmunoassay | 1 | 1994 | 175 | 0.030 |
Why?
| Catalase | 1 | 1994 | 128 | 0.030 |
Why?
| Health Promotion | 1 | 2020 | 718 | 0.030 |
Why?
| Mortality | 1 | 2016 | 308 | 0.030 |
Why?
| Pregnancy Complications | 1 | 2018 | 494 | 0.030 |
Why?
| Inflammation | 1 | 2024 | 2748 | 0.030 |
Why?
| Metals | 1 | 2014 | 123 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2017 | 1501 | 0.030 |
Why?
| Polystyrenes | 1 | 1993 | 37 | 0.030 |
Why?
| Antigens, Differentiation, T-Lymphocyte | 1 | 1993 | 88 | 0.030 |
Why?
| CD8 Antigens | 1 | 1993 | 75 | 0.030 |
Why?
| Patient Safety | 1 | 2016 | 291 | 0.030 |
Why?
| Lymphokines | 1 | 1993 | 127 | 0.030 |
Why?
| Fibronectins | 1 | 1993 | 127 | 0.020 |
Why?
| CD4 Antigens | 1 | 1993 | 137 | 0.020 |
Why?
| Pilot Projects | 1 | 2017 | 1597 | 0.020 |
Why?
| Mental Health | 1 | 2018 | 691 | 0.020 |
Why?
| Practice Guidelines as Topic | 1 | 2020 | 1514 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2017 | 1951 | 0.020 |
Why?
| Sex Characteristics | 1 | 2017 | 735 | 0.020 |
Why?
| Immunization, Passive | 2 | 1989 | 86 | 0.020 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 1993 | 836 | 0.020 |
Why?
| Heparin | 1 | 1993 | 254 | 0.020 |
Why?
| Acrylamides | 1 | 1972 | 57 | 0.020 |
Why?
| Epitopes | 4 | 1979 | 474 | 0.020 |
Why?
| Cytotoxicity, Immunologic | 2 | 1989 | 220 | 0.020 |
Why?
| CD52 Antigen | 1 | 1990 | 4 | 0.020 |
Why?
| Blood Proteins | 1 | 1973 | 245 | 0.020 |
Why?
| Chronic Disease | 1 | 2017 | 1724 | 0.020 |
Why?
| Thymus Neoplasms | 1 | 1990 | 22 | 0.020 |
Why?
| Thymoma | 1 | 1990 | 33 | 0.020 |
Why?
| Mice, Inbred DBA | 2 | 1988 | 191 | 0.020 |
Why?
| Isoelectric Focusing | 2 | 1988 | 35 | 0.020 |
Why?
| Virus Replication | 1 | 1993 | 453 | 0.020 |
Why?
| T-Lymphocytes, Regulatory | 1 | 1993 | 373 | 0.020 |
Why?
| Proteins | 2 | 1993 | 944 | 0.020 |
Why?
| Disease Progression | 1 | 2017 | 2628 | 0.020 |
Why?
| Interleukin-2 | 1 | 1990 | 437 | 0.020 |
Why?
| Dinitrophenols | 1 | 1988 | 8 | 0.020 |
Why?
| Trinitrobenzenes | 1 | 1988 | 14 | 0.020 |
Why?
| 2,4-Dinitrophenol | 1 | 1988 | 9 | 0.020 |
Why?
| Rats, Nude | 1 | 1988 | 27 | 0.020 |
Why?
| Oxidative Stress | 1 | 1995 | 1264 | 0.020 |
Why?
| Tumor Cells, Cultured | 1 | 1990 | 931 | 0.020 |
Why?
| Esterases | 3 | 1968 | 15 | 0.020 |
Why?
| Antigen-Antibody Reactions | 3 | 1975 | 54 | 0.020 |
Why?
| Embryo, Mammalian | 1 | 1969 | 224 | 0.020 |
Why?
| Postoperative Complications | 1 | 2020 | 2481 | 0.020 |
Why?
| Lymphoma | 1 | 1990 | 198 | 0.020 |
Why?
| Hybridomas | 2 | 1993 | 235 | 0.020 |
Why?
| Bone Marrow Cells | 1 | 1989 | 302 | 0.020 |
Why?
| Medicare | 1 | 2013 | 719 | 0.020 |
Why?
| Immunotherapy | 2 | 1989 | 596 | 0.020 |
Why?
| In Vitro Techniques | 1 | 1989 | 1092 | 0.020 |
Why?
| Rats | 7 | 1988 | 5487 | 0.020 |
Why?
| Sheep | 4 | 1981 | 845 | 0.020 |
Why?
| Amino Acid Sequence | 2 | 1993 | 2057 | 0.020 |
Why?
| Carcinoma, Hepatocellular | 1 | 1969 | 270 | 0.020 |
Why?
| Immunoglobulin E | 1 | 1988 | 330 | 0.020 |
Why?
| Isoelectric Point | 1 | 1986 | 23 | 0.020 |
Why?
| Heart Failure | 1 | 2020 | 2148 | 0.020 |
Why?
| Electrophoresis | 4 | 1968 | 31 | 0.020 |
Why?
| Chromium Radioisotopes | 1 | 1986 | 4 | 0.020 |
Why?
| Leukocytes, Mononuclear | 1 | 1989 | 546 | 0.020 |
Why?
| Abortion, Veterinary | 1 | 1986 | 2 | 0.020 |
Why?
| Methods | 2 | 1979 | 64 | 0.020 |
Why?
| Fetal Resorption | 1 | 1985 | 2 | 0.010 |
Why?
| Fetal Death | 1 | 1985 | 55 | 0.010 |
Why?
| Follow-Up Studies | 1 | 2013 | 4896 | 0.010 |
Why?
| Liver Neoplasms | 1 | 1969 | 636 | 0.010 |
Why?
| Neoplasm Transplantation | 4 | 1984 | 253 | 0.010 |
Why?
| Cell Nucleus | 4 | 1968 | 590 | 0.010 |
Why?
| Precipitin Tests | 2 | 1975 | 98 | 0.010 |
Why?
| Immunoglobulin Constant Regions | 1 | 1983 | 7 | 0.010 |
Why?
| Phenylalanine | 1 | 1963 | 65 | 0.010 |
Why?
| H-2 Antigens | 2 | 1986 | 115 | 0.010 |
Why?
| Cells, Cultured | 2 | 1990 | 4102 | 0.010 |
Why?
| Interferon Type I | 1 | 1984 | 139 | 0.010 |
Why?
| Acetates | 1 | 1963 | 100 | 0.010 |
Why?
| Chromatography | 2 | 1973 | 25 | 0.010 |
Why?
| Perfusion | 1 | 1963 | 197 | 0.010 |
Why?
| T-Lymphocytes, Helper-Inducer | 1 | 1983 | 135 | 0.010 |
Why?
| Hybrid Cells | 1 | 1981 | 48 | 0.010 |
Why?
| Clone Cells | 2 | 1979 | 262 | 0.010 |
Why?
| Receptors, Fc | 1 | 1981 | 52 | 0.010 |
Why?
| Research | 1 | 1963 | 420 | 0.010 |
Why?
| Lymphocyte Culture Test, Mixed | 2 | 1993 | 50 | 0.010 |
Why?
| Injections, Subcutaneous | 1 | 1979 | 146 | 0.010 |
Why?
| Papain | 1 | 1979 | 5 | 0.010 |
Why?
| Thymus Gland | 1 | 1979 | 309 | 0.010 |
Why?
| Genes | 1 | 1978 | 225 | 0.010 |
Why?
| Genetic Linkage | 1 | 1978 | 296 | 0.010 |
Why?
| Mitochondria | 1 | 1963 | 875 | 0.010 |
Why?
| Immunosorbent Techniques | 1 | 1976 | 20 | 0.010 |
Why?
| Spleen | 3 | 1979 | 508 | 0.010 |
Why?
| Sarcoma, Experimental | 1 | 1976 | 7 | 0.010 |
Why?
| Vaccination | 1 | 1985 | 1348 | 0.010 |
Why?
| Horseradish Peroxidase | 1 | 1976 | 28 | 0.010 |
Why?
| Glutaral | 1 | 1975 | 15 | 0.010 |
Why?
| Staining and Labeling | 1 | 1976 | 143 | 0.010 |
Why?
| Antigens, Heterophile | 1 | 1975 | 5 | 0.010 |
Why?
| Immunoassay | 1 | 1976 | 108 | 0.010 |
Why?
| Cytoplasm | 1 | 1976 | 269 | 0.010 |
Why?
| Fluorescent Antibody Technique | 1 | 1976 | 377 | 0.010 |
Why?
| Cell Differentiation | 2 | 1974 | 1900 | 0.010 |
Why?
| Antibody-Producing Cells | 1 | 1974 | 30 | 0.010 |
Why?
| Chromatography, Gel | 1 | 1974 | 126 | 0.010 |
Why?
| Protein Biosynthesis | 1 | 1976 | 406 | 0.010 |
Why?
| Globulins | 1 | 1973 | 1 | 0.010 |
Why?
| Chloroform | 1 | 1973 | 4 | 0.010 |
Why?
| Immunoglobulin Fragments | 1 | 1973 | 11 | 0.010 |
Why?
| Thermolysin | 1 | 1993 | 4 | 0.010 |
Why?
| Blood Protein Electrophoresis | 1 | 1973 | 8 | 0.010 |
Why?
| Gene Expression Regulation | 1 | 1983 | 2545 | 0.010 |
Why?
| Absorption | 1 | 1993 | 59 | 0.010 |
Why?
| CD57 Antigens | 1 | 1993 | 16 | 0.010 |
Why?
| Chick Embryo | 1 | 1973 | 130 | 0.010 |
Why?
| Solubility | 1 | 1973 | 232 | 0.010 |
Why?
| Microspheres | 1 | 1993 | 131 | 0.010 |
Why?
| Hydrolysis | 1 | 1993 | 186 | 0.010 |
Why?
| Immunoenzyme Techniques | 1 | 1993 | 211 | 0.010 |
Why?
| Iodine Radioisotopes | 1 | 1993 | 143 | 0.010 |
Why?
| Chickens | 1 | 1973 | 188 | 0.010 |
Why?
| Immunochemistry | 1 | 1972 | 13 | 0.010 |
Why?
| Immunologic Techniques | 1 | 1972 | 39 | 0.010 |
Why?
| Animals, Newborn | 1 | 1974 | 834 | 0.010 |
Why?
| Evaluation Studies as Topic | 1 | 1972 | 176 | 0.010 |
Why?
| Cell Membrane | 1 | 1975 | 734 | 0.010 |
Why?
| Muramidase | 1 | 1972 | 77 | 0.010 |
Why?
| Leukocytes | 1 | 1973 | 306 | 0.010 |
Why?
| Alkaline Phosphatase | 1 | 1972 | 147 | 0.010 |
Why?
| Cholinesterases | 2 | 1968 | 10 | 0.010 |
Why?
| Deoxyribonucleases | 2 | 1968 | 23 | 0.010 |
Why?
| Aldehydes | 1 | 1972 | 144 | 0.010 |
Why?
| Lipoproteins | 1 | 1971 | 172 | 0.010 |
Why?
| L-Lactate Dehydrogenase | 2 | 1968 | 119 | 0.010 |
Why?
| Protein Conformation | 1 | 1993 | 861 | 0.010 |
Why?
| Blotting, Western | 1 | 1993 | 1204 | 0.010 |
Why?
| Endoplasmic Reticulum | 1 | 1971 | 261 | 0.000 |
Why?
| Ethanol | 1 | 1973 | 591 | 0.000 |
Why?
| Molecular Sequence Data | 1 | 1993 | 2833 | 0.000 |
Why?
| Protein Binding | 1 | 1993 | 2123 | 0.000 |
Why?
| Liver Diseases | 1 | 1969 | 291 | 0.000 |
Why?
| Enzymes | 1 | 1966 | 67 | 0.000 |
Why?
| T-Lymphocytes, Cytotoxic | 1 | 1986 | 170 | 0.000 |
Why?
| Genetic Variation | 1 | 1970 | 937 | 0.000 |
Why?
| Fetal Viability | 1 | 1985 | 3 | 0.000 |
Why?
| Mice, Inbred CBA | 1 | 1985 | 53 | 0.000 |
Why?
| Pronase | 1 | 1981 | 5 | 0.000 |
Why?
| Rosette Formation | 1 | 1981 | 16 | 0.000 |
Why?
| Trypsin | 1 | 1981 | 74 | 0.000 |
Why?
| Contact Inhibition | 2 | 1970 | 5 | 0.000 |
Why?
| Culture Techniques | 2 | 1970 | 81 | 0.000 |
Why?
| Lymphocyte Activation | 1 | 1985 | 1110 | 0.000 |
Why?
| Receptors, Antigen, T-Cell | 1 | 1985 | 707 | 0.000 |
Why?
| Ascitic Fluid | 1 | 1979 | 14 | 0.000 |
Why?
| Microscopy, Electron | 2 | 1970 | 425 | 0.000 |
Why?
| Histocompatibility Antigens Class II | 1 | 1981 | 363 | 0.000 |
Why?
| Epithelium | 2 | 1970 | 311 | 0.000 |
Why?
| beta-Galactosidase | 1 | 1979 | 77 | 0.000 |
Why?
| Cell Cycle | 1 | 1981 | 583 | 0.000 |
Why?
| Placenta | 1 | 1985 | 716 | 0.000 |
Why?
| Fibroblasts | 2 | 1970 | 954 | 0.000 |
Why?
| Neuraminic Acids | 1 | 1972 | 1 | 0.000 |
Why?
| Densitometry | 1 | 1972 | 34 | 0.000 |
Why?
| Vibrio cholerae | 1 | 1972 | 12 | 0.000 |
Why?
| Neuraminidase | 1 | 1972 | 25 | 0.000 |
Why?
| Ultracentrifugation | 1 | 1972 | 48 | 0.000 |
Why?
| Microsomes, Liver | 1 | 1972 | 87 | 0.000 |
Why?
| Leukemia Virus, Murine | 1 | 1970 | 17 | 0.000 |
Why?
| Intestines | 1 | 1972 | 350 | 0.000 |
Why?
|
|
Stanislawski's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|